Rhythm Pharmaceuticals, Inc. (RYTM) Discusses FDA Approval of IMCIVREE for Acquired Hypothalamic Obesity - Slideshow (NASDAQ:RYTM) 2026-03-24
TD Cowen reitera recomendación de Compra en Rhythm Pharmaceuticals con precio objetivo de 130 dólares